Deficient Mismatch Repair Proteins in Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasm: A Rare Case Report

被引:1
|
作者
Nguyen, Thi Hong Chuyen [1 ]
Tran, Bao Song Nguyen [2 ]
Nguyen, Thanh Phuc [3 ]
Ha, Thi Minh Thi [4 ]
Pham, Nguyen Cuong [5 ]
Nguyen, Thu Giang Thi [1 ]
Hoang, Huu [1 ]
Cong, Thuan Dang [2 ]
机构
[1] Hue Univ, Hue Univ Med & Pharm, Dept Oncol, Hue, Vietnam
[2] Hue Univ, Hue Univ Med & Pharm, Dept Histol Embryol Pathol & Forens Med, Hue, Vietnam
[3] Hue Univ, Hue Univ Med & Pharm, Dept Anat & Surg Training, Hue, Vietnam
[4] Hue Univ, Hue Univ Med & Pharm, Dept Med Genet, Hue, Vietnam
[5] Hue Cent Hosp, Dept Pathol, Hue, Vietnam
来源
CASE REPORTS IN ONCOLOGY | 2023年 / 16卷 / 01期
关键词
Microsatellite instability; Mismatch repair protein; Gastric cancer; Adjuvant chemotherapy; Gastric mixed neuroendocrine non-neuroendocrine neoplasm; ADENONEUROENDOCRINE CARCINOMA;
D O I
10.1159/000533707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) is a rare type of gastric carcinoma with controversial diagnosis and treatment. Recent data implies that deficiency mismatch repair proteins inducing microsatellite instability are considered one of the potential drivers of this disease. Hence, we report a stomach MiNEN with MMR protein loss. An admitted 60-year-old woman complained of epigastric pain. The pathological analysis of the gastro-endoscopic biopsy specimen revealed gastric adenocarcinoma. The radiological staging was cT3N1M0; therefore, she received D2 distal gastrectomy. Suspecting neuroendocrine component admix with adenocarcinoma part on the resected specimen microscopy, applying biomarkers including AE 1/3, synaptophysin, and chromogranin A to confirm the diagnosis of MiNEN. The neuroendocrine part was classified as neuroendocrine tumor grade 2 with Ki 67 at 16.5%. To further understand the molecular characterization of this disease, we evaluated mismatch protein expression by staining MLH1, MSH2, MSH6, and PMS2 antibodies. Interestingly, both components lost MLH1 and PMS2 proteins. Her radical surgery followed oxaliplatin/capecitabine adjuvant chemotherapy. The patient is still well after eight cycles of chemotherapy. dMMR gastric MiNENs and dMMR gastric cancer share many clinical and genetic characteristics. Further studies are necessary to survey the role of dMMR in the prognosis and treatment of this entity.
引用
收藏
页码:1172 / 1182
页数:11
相关论文
共 50 条
  • [41] Mixed neuroendocrine non-neuroendocrine tumors: The quest for evidence
    Cives, Mauro
    Porta, Camillo
    Palmirotta, Raffaele
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (12)
  • [42] Unusual Microsatellite-Instable Mixed Neuroendocrine and Non-neuroendocrine Neoplasm: A Clinicopathological Inspection and Literature Review
    Pereira, Daniela
    White, Daley
    Mortellaro, Michael
    Jiang, Kun
    CANCER CONTROL, 2023, 30
  • [43] Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma
    Dasaraju, Sandhyarani
    Amin, Khalid
    Klein, Molly E.
    Rivard, Colleen
    Mattson, Jordan
    Davidson, Sarah
    Khalifa, Mahmoud A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 44
  • [44] Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
    Jingci Chen
    Pengyan Wang
    Ke Lv
    Weixun Zhou
    Diagnostic Pathology, 16
  • [45] Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
    Chen, Jingci
    Wang, Pengyan
    Lv, Ke
    Zhou, Weixun
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [46] Mixed neuroendocrine non-neuroendocrine neoplasm combining neuroendocrine tumor with hepatocellular carcinoma in the context of multiple endocrine neoplasia type 1
    Mulsant, Madeleine
    Mosnier, Jean-Francois
    Frampas, Eric
    Matysiak-Budnik, Tamara
    Jamet, Bastien
    Touchefeu, Yann
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (02)
  • [47] Rare Non-Neuroendocrine Pancreatic Tumours
    Mormul, Agata
    Wloszek, Emilia
    Nowoszewska, Julia
    Fudalej, Marta
    Budzik, Michal
    Badowska-Kozakiewicz, Anna
    Deptala, Andrzej
    CANCERS, 2023, 15 (08)
  • [48] CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
    Yanqi Zhong
    Heng Zhang
    Xian Wang
    Zongqiong Sun
    Yuxi Ge
    Weiqiang Dou
    Shudong Hu
    Insights into Imaging, 14
  • [49] Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas
    Niessen, Anna
    Schimmack, Simon
    Weber, Tim F.
    Mayer, Philipp
    Bergmann, Frank
    Hinz, Ulf
    Buechler, Markus W.
    Strobel, Oliver
    PANCREATOLOGY, 2021, 21 (01) : 224 - 235
  • [50] Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?
    Dhakre, Vijay W. W.
    Galande, Sneha Tukaram
    Patil, Varsha Gunvant
    Shah, Nikita C.
    Rathod, Chetan
    Sethna, Kaiumarz S.
    Amrapurkar, Anjali D.
    GASTROINTESTINAL TUMORS, 2023, 10 (01) : 14 - 18